Literature DB >> 7052014

[The EEG of patients with acute manic psychoses before, during and after treatment with high doses of d-propranolol and dl-propranolol (author's transl)].

K Coulin, O Simon, H M Emrich, D von Zerssen.   

Abstract

Six manic patients, drug-free for at least 10 days, were treated with high doses (up to 3,000 mg/day, corresponding serum levels up to 1,600 ng/ml) of d-propranolol or dl-propranolol in a double-blind, placebo-controlled study. The EEG's of these patients were studied over a maximum period of 21 days. All 82 EEG's were normal, they showed neither epileptic patterns nor any other signs for hypersynchronisation, as a possible side-effect of propranolol, nor other abnormalities, due to the manic condition. Analysis by fast-fourier-transformation produced no difference between the effect of d-propranolol or dl-propranolol on EEG compared intra- and inter-hemispherically by power-spectra, cross-spectra, phase-differences and coherences. At high serum levels (more than 1,000 ng/ml) there was a corresponding increase of power and a drop in frequency of the alpha-activity, maximally--1.1 c/s, which probably depended on the serum level. This result is in agreement with the hypothesis of a direct antimanic effect of the drug and comparable to the clinical effect of lithium, which produces similar changes in EEG. A comparison of the propranolol-induced EEG changes with EEG changes usually induced by sedative drugs, contradicts the hypothesis that the antimatic properties of propranolol are caused by unspecific sedation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7052014     DOI: 10.1007/bf00345588

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  23 in total

1.  The short-term effects of adrenergic-blocking agents in a small group of psychotic patients. Preliminary clinical observations.

Authors:  A Atsmon; I Blum; H Wijsenbeek; B Maoz; M Steiner; G Ziegelman
Journal:  Psychiatr Neurol Neurochir       Date:  1970 May-Jun

2.  Treatment of acute prophyria variegata with propranolol.

Authors:  A Atsmon; I Blum
Journal:  Lancet       Date:  1970-01-24       Impact factor: 79.321

3.  Central nervous system effects and metabolic disposition of a glycol metabolite of propranolol.

Authors:  D A Saelens; T Walle; P J Privitera; D R Knapp; T Gaffney
Journal:  J Pharmacol Exp Ther       Date:  1974-01       Impact factor: 4.030

4.  CNS effects of propranolol in man.

Authors:  M H Orzack; R Branconnier; G Gardos
Journal:  Psychopharmacologia       Date:  1973

5.  Psychiatric uses of beta-blockers.

Authors:  H Cuche; P Deniker
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1980-09

6.  [The effect of the beta-adrenergic blocking agent propranolol in mania (author's transl)].

Authors:  W Rackensperger; W Fritsch; D Schwarz; K H Stutte; D Zerssen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-10-28

7.  Propranolol in chronic schizophrenia: a controlled study in neuroleptic-treated patients.

Authors:  L H Lindström; E Persson
Journal:  Br J Psychiatry       Date:  1980-08       Impact factor: 9.319

8.  The clinical laboratory and electroencephalographic effects of lithium.

Authors:  D Mayfield; R G Brown
Journal:  J Psychiatr Res       Date:  1966-12       Impact factor: 4.791

9.  Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders.

Authors:  H M Emrich; D von Zerssen; W Kissling; H J Möller; A Windorfer
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1980

10.  Central and peripheral effects of propranolol and sotalol in normal human subjects.

Authors:  M H Lader; P J Tyrer
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.